266 related articles for article (PubMed ID: 38018578)
1. The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer.
Wang S; Zhang G; Cui Q; Yang Y; Wang D; Liu A; Xia Y; Li W; Liu Y; Yu J
Immun Inflamm Dis; 2023 Nov; 11(11):e1099. PubMed ID: 38018578
[TBL] [Abstract][Full Text] [Related]
2. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
3. [CAR-T Immunotherapy and Non-small Cell Lung Cancer: Bottleneck and Dawn].
Zhang L; Li H; Zhang F; Wang S; Li G
Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):916-920. PubMed ID: 32810975
[TBL] [Abstract][Full Text] [Related]
4. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances and Future Perspective of DC-Based Therapy in NSCLC.
van der Hoorn IAE; Flórez-Grau G; van den Heuvel MM; de Vries IJM; Piet B
Front Immunol; 2021; 12():704776. PubMed ID: 34262573
[TBL] [Abstract][Full Text] [Related]
6. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
7. Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype.
Palata O; Podzimkova Hradilova N; Mysiková D; Kutna B; Mrazkova H; Lischke R; Spisek R; Adkins I
Immunol Lett; 2020 Mar; 219():46-53. PubMed ID: 31931024
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma.
Zhang Y; Hu X; Hu Y; Teng K; Zhang K; Zheng Y; Hong X; Yu K; Wang Y; Liu L
J Exp Clin Cancer Res; 2015 Feb; 34(1):11. PubMed ID: 25651850
[TBL] [Abstract][Full Text] [Related]
9.
Bamodu OA; Kuo KT; Wang CH; Huang WC; Wu ATH; Tsai JT; Lee KY; Yeh CT; Wang LS
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547048
[TBL] [Abstract][Full Text] [Related]
10. Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
Hradilova N; Sadilkova L; Palata O; Mysikova D; Mrazkova H; Lischke R; Spisek R; Adkins I
PLoS One; 2017; 12(2):e0171539. PubMed ID: 28187172
[TBL] [Abstract][Full Text] [Related]
11. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
[TBL] [Abstract][Full Text] [Related]
12. Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives.
Qu J; Mei Q; Chen L; Zhou J
Cancer Immunol Immunother; 2021 Mar; 70(3):619-631. PubMed ID: 33025047
[TBL] [Abstract][Full Text] [Related]
13. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
14. Effect of ginseng polysaccharides and dendritic cells on the balance of Th1/Th2 T helper cells in patients with non-small cell lung cancer.
Ma J; Liu H; Wang X
J Tradit Chin Med; 2014 Dec; 34(6):641-5. PubMed ID: 25618966
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy.
Mayoux M; Roller A; Pulko V; Sammicheli S; Chen S; Sum E; Jost C; Fransen MF; Buser RB; Kowanetz M; Rommel K; Matos I; Colombetti S; Belousov A; Karanikas V; Ossendorp F; Hegde PS; Chen DS; Umana P; Perro M; Klein C; Xu W
Sci Transl Med; 2020 Mar; 12(534):. PubMed ID: 32161104
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.
Morisaki T; Matsumoto K; Onishi H; Kuroki H; Baba E; Tasaki A; Kubo M; Nakamura M; Inaba S; Yamaguchi K; Tanaka M; Katano M
Hum Cell; 2003 Dec; 16(4):175-82. PubMed ID: 15147037
[TBL] [Abstract][Full Text] [Related]
17. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
18. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
Dieu-Nosjean MC; Antoine M; Danel C; Heudes D; Wislez M; Poulot V; Rabbe N; Laurans L; Tartour E; de Chaisemartin L; Lebecque S; Fridman WH; Cadranel J
J Clin Oncol; 2008 Sep; 26(27):4410-7. PubMed ID: 18802153
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells cross-talk with tumour antigen-specific CD8
Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M
Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488
[TBL] [Abstract][Full Text] [Related]
20. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.
Tacken PJ; de Vries IJ; Gijzen K; Joosten B; Wu D; Rother RP; Faas SJ; Punt CJ; Torensma R; Adema GJ; Figdor CG
Blood; 2005 Aug; 106(4):1278-85. PubMed ID: 15878980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]